Skip to main content
. 2019 Nov 7;25:100432. doi: 10.1016/j.ijcha.2019.100432

Table 2.

Subgroup analysis of acetoacetate (per 10 µmoL/L increase) for all-cause death.

Factor Subgroup N HR 95%CI P value InteractionP value
Total 615 1.020 1.010–1.030 <0.001
Age Age 67 years < 245 0.932 0.784–1.104 0.402 0.284
Age 67 years ≥ 370 1.020 1.010–1.020 <0.001
Sex Male 374 1.010 1.001–1.020 0.004 0.005
Female 241 1.051 1.030–1.083 <0.001
NYHA classification I, II 362 1.041 1.041–1.051 <0.001 0.001
III, IV 253 1.010 0.990–1.020 0.335
Ischemic etiology ± 147 1.010 1.001–1.020 0.047 0.110
468 1.030 1.010–1.040 <0.001
Hypertension ± 395 1.010 1.001–1.030 0.011 0.094
220 1.030 1.010–1.041 <0.001
Diabetes mellitus ± 256 1.010 1.000–1.020 0.057 0.013
359 1.041 1.020–1.051 <0.001
Dyslipidemia ± 392 1.020 1.010–1.030 <0.001 0.668
223 1.010 0.990–1.041 0.305
Atrial fibrillation ± 249 1.030 1.010–1.051 0.015 0.479
336 1.020 1.010–1.030 <0.001
Chronic kidney disease ± 324 1.030 1.020–1.051 <0.001 0.060
291 1.010 1.000–1.030 0.026
Anemia ± 293 1.010 1.010–1.020 <0.001 0.590
322 1.020 1.000–1.051 0.094
Log BNP Mean 2.3 ≥ 340 1.010 1.001–1.020 0.042 0.007
Mean 2.3 < 275 1.030 1.020–1.041 <0.001

HR, hazard ratio; CI, confidence interval; NYHA, New York Heart Association; BNP, B-type natriuretic peptide.